Cargando…
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study
BACKGROUND: Patients with chronic lymphocytic leukemia (CLL) have reduced seroconversion rates and lower binding antibody (Ab) and neutralizing antibody (NAb) titers than healthy individuals following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA vaccination. Here, we dissected v...
Autores principales: | Qin, Kai, Honjo, Kazuhito, Sherrill-Mix, Scott, Liu, Weimin, Stoltz, Regina M., Oman, Allisa K., Hall, Lucinda A., Li, Ran, Sterrett, Sarah, Frederick, Ellen R., Lancaster, Jeffrey R., Narkhede, Mayur, Mehta, Amitkumar, Ogunsile, Foluso J., Patel, Rima B., Ketas, Thomas J., Cruz Portillo, Victor M., Cupo, Albert, Larimer, Benjamin M., Bansal, Anju, Goepfert, Paul A., Hahn, Beatrice H., Davis, Randall S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309642/ https://www.ncbi.nlm.nih.gov/pubmed/37384638 http://dx.doi.org/10.1371/journal.pmed.1004157 |
Ejemplares similares
-
SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia
por: Qin, Kai, et al.
Publicado: (2022) -
Predictors of Nonseroconversion after SARS-CoV-2 Infection
por: Liu, Weimin, et al.
Publicado: (2021) -
CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges
por: Narkhede, Mayur, et al.
Publicado: (2021) -
Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
por: Honjo, Kazuhito, et al.
Publicado: (2020) -
Primary effusion lymphoma: current perspectives
por: Narkhede, Mayur, et al.
Publicado: (2018)